FDA Inspection
Octapharma Plasma IncOctapharma Plasma Inc – FDA Inspection, Aug 29, 2024
Record Details
This FDA Inspection record concerns Octapharma Plasma Inc, with an inspection on August 29, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 02cffa56-07c0-46df-9718-1a7f7ca48c58
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1250909
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Octapharma Plasma Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 23, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 22, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 30, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 19, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 11, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma Inc
- FDA Inspection 1329120 - 2026-07-23
- FDA Inspection 1317018 - 2026-04-22
- FDA Inspection 1312082 - 2026-03-30
- FDA Inspection 1310204 - 2026-03-19
- FDA Inspection 1282432 - 2026-03-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.